Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report Publisher Pubmed

Rezaie Z¹ ; Taghizadehghehi M² ; Jafarzadeh Kohneloo A³

Show Affiliations

1. Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2. Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, 4th floor, No 92, Karimkhan Zand Ave., Hafte Tir Sq, Tehran, Iran
3. Department of Epidemiology and Biostatistics, Faculty of Health, Tehran University of Medical Sciences, Tehran, Iran

Source: European Journal of Clinical Pharmacology Published:2021

Abstract

[No abstract available]

Style	Citing Format
MLA	Rezaie Z, Taghizadehghehi M, Jafarzadeh Kohneloo A. "Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report." European Journal of Clinical Pharmacology, vol. 77, no. 9, 2021, pp. 1429-1430.
APA	Rezaie Z, Taghizadehghehi M, Jafarzadeh Kohneloo A (2021). Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report. European Journal of Clinical Pharmacology, 77(9), 1429-1430.
Chicago	Rezaie Z, Taghizadehghehi M, Jafarzadeh Kohneloo A. "Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report." European Journal of Clinical Pharmacology 77, no. 9 (2021): 1429-1430.
Harvard	Rezaie Z, Taghizadehghehi M, Jafarzadeh Kohneloo A (2021) 'Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report', European Journal of Clinical Pharmacology, 77(9), pp. 1429-1430.
Vancouver	Rezaie Z, Taghizadehghehi M, Jafarzadeh Kohneloo A. Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report. European Journal of Clinical Pharmacology. 2021;77(9):1429-1430.
BibTex	@article{ author = {Rezaie Z and Taghizadehghehi M and Jafarzadeh Kohneloo A}, title = {Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report}, journal = {European Journal of Clinical Pharmacology}, volume = {77}, number = {9}, pages = {1429-1430}, year = {2021} }
RIS	TY - JOUR AU - Rezaie Z AU - Taghizadehghehi M AU - Jafarzadeh Kohneloo A TI - Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report JO - European Journal of Clinical Pharmacology VL - 77 IS - 9 SP - 1429 EP - 1430 PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract